Oxytocin therapy in children with autism spectrum disorder and co-occurring intellectual disability: examination of desirability, clinical efficacy and therapeutic augmentation by psychosocial training KU Leuven
Intranasal administration of oxytocin is increasingly considered a new therapeutic resource for autism spectrum disorder (ASD). Prior oxytocin trials have however mostly excluded autistic individuals with co-occurring intellectual disability (ID) by design, despite making up 40% of the ASD population and often displaying more severe symptoms. Therefore, we propose a RCT assessing the clinical effects of a multiple-dose oxytocin intervention ...